Emisphere Technologies

Emisphere Technologies Inc is a pharmaceutical and drug delivery company. Its goal is to collaborate with its proprietary drug delivery technology and obtain the licensing for its first medical food product, Eligen B12, which is used to normalize vitamin B12 levels without injections. The company partners with global pharmaceutical firms to develop new oral formulations of existing injectable biopharmaceutical products using its Eligen technology, as well as new chemical entities. The company recognizes revenue through sales of Eligen B12 and prescription products.